Thermo Fisher Scientific Inc. (TMO)
Upgrades & Downgrades
Latest TMO news
Danaher And Thermo Fisher: Buy These High-Quality Compounders At A Fair Price
17 June 2022
Two healthcare giants - Danaher and Thermo Fisher - are finally trading at a fair price. Over the last decades, both companies shown a great track record of excellent operations.
3 Growth Stocks That Raised Their Guidance This Year
14 June 2022
These companies are bullish on 2022.
Thermo Fisher's (TMO) Autoimmune Disease Test Gets FDA Nod
10 June 2022
Thermo Fisher's (TMO) RNA Polymerase III and EliA Rib-P blood tests are intended to diagnose systemic sclerosis and systemic lupus erythematosus.
Thermo Fisher (TMO) to Promote Mass Spectrometry Imaging
9 June 2022
Thermo Fisher's (TMO) new deal with TransMIT will advance the use of the AP-SMALDI5 AF ion source with Orbitrap MS technology for spatial multi-omics applications.
Thermo Fisher (TMO) North America Sales Grow, Margin Woe Stays
1 June 2022
Thermo Fisher (TMO) witnesses core business strength across segments, end markets, and geographies.
Best Health Care Stocks To Invest In 2022? 3 Names To Watch
26 May 2022
Here are 3 top health care stocks to watch in the stock market right now.
Thermo Fisher (TMO) to Advance Precision Medicine in Qatar
24 May 2022
Thermo Fisher's (TMO) collaboration with Qatar Genome Program will utilize the power of genomics to enhance the standard of healthcare for the Qatari population.
This Growth Stock Is Raising Guidance Despite Multiple Headwinds
13 May 2022
The company is coming off a strong quarter and expects that pattern to continue.
Thermo Fisher Scientific to Present at BofA Securities 2022 Healthcare Conference
6 May 2022
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will pr...